The UK's Institute of Cancer Research is collaborating with scientists at AB SCIEX to standardize advanced methods of mass spectrometry-based tissue imaging.
The UK’s Institute of Cancer Research is collaborating with scientists at AB SCIEX to standardize advanced methods of mass spectrometry-based tissue imaging. ICR researchers are using the company’s mass spectrometry technology to better understand this spread of disease, known as metastasis, which is responsible for approximately 90% of cancer patient deaths.
"One of our major goals at The Institute of Cancer Research is to contribute to the development of new anti-cancer treatments”, said Janine Erler, Team Leader at the ICR. “This collaboration with AB SCIEX on mass spectrometry-based imaging will help us discover new molecules that are critical to cancer spread."
The ICR is contributing to efforts to address the progression of cancer by studying communication between cells associated with the spread of cancer, revealing molecules involved in metastasis that can be targeted with new drugs.
The collaboration enhances this research project by applying the latest in high-resolution, tissue imaging technology to investigate how aspects of the tumour micro-environment drive the spread of cancer. The cancer researchers are using mass spectrometry to conduct non-targeted discovery, looking at specific regions of the tumour, investigating proteins that are present in these regions and how they enhance metastatic progression.
The technology being used is the AB SCIEX TOF/TOF 5800 system, a matrix-assisted laser desorption/ionization time-of-flight mass spectrometry system. Dave Hicks, vice president and general manager of the pharmaceutical and proteomics business at the company said; "We are committed to continue helping researchers of cancer and other diseases apply the power of mass spectrometry to uncover new information that could lead to major breakthroughs and new developments in drugs. Our broad range of technologies allows scientists to choose what is most appropriate for their research. With Dr Erler's team at The Institute of Cancer Research, we were able to meet their need for advanced imaging technology that is contributing to the success of their important research."
For more information about the institute visit www.icr.ac.uk and for more on the company go to www.absciex.com
Sustainable Green Solvents in Microextraction: A Review of Recent Advancements
March 27th 2024Conventional sample preparation can be time- and resource-consuming, and a green analytical methodology can be a game-changer for scientists, in addition to facilitating selective and sensitive separations.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.
High-Throughput Analysis of Volatile Compounds in Air, Water, and Soil Using SIFT-MS (Apr 2024)
March 27th 2024This study demonstrates high-throughput analysis of BTEX compounds from several matrices (air, water and soil). Detection limits in the single-digit part-per-billion concentration range (by volume) are readily achievable within seconds using SIFT-MS, because sample analysis is achieved without chromatography, pre-concentration, or drying. We also present a calibration approach that enables speciation of ethylbenzene from the xylenes in real time.